Review
Aug 2026
Modalities to identify clinically actionable neoantigens.
Recent experimental platforms have been developed to validate neoantigen immunogenicity, which can be complemented by single-cell RNA/T-cell receptor sequencing to identify tumor-reactive T cell clones.
Takamasa Ishino, Yosuke Togashi
· The FEBS Journal · 0 citations